Mustafa ARGA, Erdem TOPAL, Sıla YILMAZ, Pınar Canızcı ERDEMLİ, Kübra BIÇAKCI, Arzu BAKIRTAŞ

Healthcare workers’ knowledge level regarding anaphylaxis and usage of epinephrine auto-injectors

Background. Inadequate practices in diagnosis and management of anaphylaxis in parallel with an increase in its prevalence may cause serious public health problems today. This is the first study aiming to assess the theoretical knowledge of professional and non-professional healthcare workers from different lines of the healthcare service chain about anaphylaxis management, and their practice approaches for epinephrine autoinjectors (EAIs) together. Methods. The study included 697 participants comprising physicians, dentists, pharmacists, and school staff. In face-to-face interviews, each participant was asked to fill out the questionnaire forms prepared for assessing their demographic characteristics, experience with a case of anaphylaxis and EAI and theoretical knowledge about the diagnosis and treatment of anaphylaxis, and to demonstrate how to use EAI in practice with trainer device. Results. The rates of 391 physicians, 98 dentists, 102 pharmacists and 105 school staff of knowing the diagnosis criteria of anaphylaxis were 47.6%, 31.6%, 31.1%, 19%, and knowing the first and life-saving treatment of anaphylaxis were 87.2%, 79.6%, 47.6%, 15.2%, respectively. Predictors that affected physicians in knowing the first and life-saving treatment of anaphylaxis were having experience with EAIs [OR:5.5, (%95CI:1.330-23.351, p=0.015)] and a case of anaphylaxis [OR:2.4, (%95CI:1.442-4.020, p=0.001)], and knowing the administration route of epinephrine correctly [OR:1.9, (%95CI:1.191-3.314, p=0.008)]. 31.1% of the participants demonstrated the EAI usage correctly. The EAI usage steps with the most errors were “Place the appropriate injection tip into outer thigh/Press the trigger so it ‘clicks’” and “Turn the trigger to arrow direction” (60.3% and 34.9%, respectively). Conclusions. Healthcare workers’ knowledge level regarding anaphylaxis management and ability to use EAIs correctly are not adequate. That most errors were made in the same steps of EAI usage indicates that the industry should continue to strive for developing the ideal life-saving device.

PDF

___

1. Brown GA, Kemp SF, Lieberman PL. Anapyhylaxis. In: Adkinson NF Jr, Bochner BS, Burks WW, (eds). Middleton’s Allergy: Principles and Practice. (8th ed). Philadelphia: Saunders Inc, 2014: 1237-1260.

2. Sicherer SH, Simons FER, Section on Allergy and Immunology. Epinephrine for first-aid management of anaphylaxis. Pediatrics 2017; 139: e20164006.

3. Wang J, Sicherer SH, Section on Allergy and Immunology. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics 2017; 139: e20164005.

4. Ribeiro MLKK, Chong Neto HJ, Rosario Filho NA. Diagnosis and treatment of anaphylaxis: there is an urgent needs to implement the use of guidelines. Einstein (Sao Paulo) 2017; 15: 500-506.

5. Muraro A, Clark A, Beyer K, et al. The management of the allergic child at school: EAACI/GA2LEN task force on the allergic child at school. Allergy 2010; 65: 681-689.

6. Muraro A, Agache I, Clark A, et al; European Academy of Allergy and Clinical Immunology. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy 2014; 69: 1046-1057.

7. Vale S, Smith J, Said M, Mullins RJ, Loh R. ASCIA guidelines for prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update. J Paediatr Child Health 2015; 51: 949-954.

8. Sicherer SH, Mahr T, American Academy of Pediatrics Section on Allergy and Immunology. Management of food allergy in the school setting. Pediatrics 2010; 126: 1232-1239.

9. Orhan F, Civelek E, Sahiner UM, et al. Anafilaksi: Türk Ulusal Rehberi 2018. Astım Alerji İmmünoloji Dergisi 2018; 16(Ek sayı 1): 1-62.

10. Hogue SL, Muniz R, Herrem C, Silvia S, White MV. Barriers to the administration of epinephrine in schools. J Sch Health 2018; 88: 396-404.

11. Ercan H, Ozen A, Karatepe H, Berber M, Cengizlier R. Primary school teachers’ knowledge about and attitudes toward anaphylaxis. Pediatr Allergy Immunol 2012; 23: 428-432.

12. Tanno LK, Demoly P, Joint Allergy Academies. How can the World Health Organization’s International Classification of Diseases (ICD)-11 change the clinical management of anaphylaxis? Expert Rev Clin Immunol 2018; 14: 783-786.

13. Arga M, Bakirtas A, Catal F, et al. Training of trainers on epinephrine autoinjector use. Pediatr Allergy Immunol 2011; 22: 590-593.

14. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report– Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391- 397.

15. Muraro A, Roberts G, Worm M, et al; EAACI Food Allergy and Anaphylaxis Guidelines Group. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69: 1026-1045.

16. Topal E, Karagöl HİE, Yılmaz Ö, et al. Comparison of practical application steps of the previously used adrenaline auto injector in Turkey (EpiPen) and the currently available adrenaline auto injector (Penepin): a multi-center study. Turk Pediatri Ars 2018; 53: 149-154.

17. Altman AM, Camargo CA Jr, Simons FE, et al. Anaphylaxis in America: a national physician survey. J Allergy Clin Immunol 2015; 135: 830-833.

A, Pampura A, Warner JO. A national survey of Russian physicians’ knowledge of diagnosis and management of food-induced anaphylaxis. BMJ Open 2017; 7: e015901.

19. Grossman SL, Baumann BM, Garcia Peña BM, Linares MY, Greenberg B, Hernandez-Trujillo VP. Anaphylaxis knowledge and practice preferences of pediatric emergency medicine physicians: a national survey. J Pediatr 2013; 163: 841-846.

20. Olabarri M, Gonzalez-Peris S, Vázquez P, et al. Management of anaphylaxis in Spain: pediatric emergency care providers’ knowledge. Eur J Emerg Med 2019; 26: 163-167.

21. Solé D, Ivancevich JC, Cardona V. Knowledge of anaphylaxis among ibero-American physicians: results of the Ibero-American Online Survey for Physicians on the management and treatment of anaphylaxis (IOSPTA) -Latin American Society of Allergy, Asthma & Immunology (LASAAI). J Investig Allergol Clin Immunol 2013; 23: 441-443.

22. Arga M, Bakirtas A, Turktas I, Demirsoy MS. Pediatri asistan ve uzmanları adrenalin otoenjektör kullanımını biliyor mu? Astım Alerji İmmünoloji Dergisi 2009; 7: 26-31.

23. Erkoçoğlu M, Civelek E, Azkur D, et al. Knowledge and attitudes of primary care physicians regarding food allergy and anaphylaxis in Turkey. Allergol Immunopathol (Madr) 2013; 41: 292-297.

24. Baççıoğlu A, Yılmazel Uçar E. Level of knowledge about anaphylaxis among health care providers. Tuberk Toraks 2013; 61: 140-146.

25. Tuncel T, Sancakli O, Bag O, Cetin HS, Özdoğru EE. Physicians’ approach to anaphylaxis in childhood. Pediatr Emerg Care 2020. doi: 10.1097/PEC. 0000000000002064.

26. Derinoz O, Bakirtas A, Arga M, et al. Pediatricians manage anaphylaxis poorly regardless of episode severity. Pediatr Int 2014; 56: 323-327.

27. Cohen MB, Saunders SS, Wise SK, Nassif S, Platt MP. Pitfalls in the use of epinephrine for anaphylaxis: patient and provider opportunities for improvement. Int Forum Allergy Rhinol 2017; 7: 276-286.

28. Mahoney B, Walklet E, Bradley E, O’Hickey S. Improving adrenaline autoinjector adherence: a psychologically informed training for healthcare professionals. Immun Inflamm Dis 2019; 7: 214-228.

29. Worm M, Molaie N, Dölle S. Level of knowledge among pharmacists regarding anaphylaxis and the use of epinephrine autoinjectors. J Dtsch Dermatol Ges 2018; 16: 1315-1321.

30. Pitsios C, Vasiliadis A, Karakatsanis KP, et al. Availability of epinephrine auto-injectors and knowledge of community pharmacists about their use. Eur Ann Allergy Clin Immunol 2019; 51: 234- 236.

31. Salter SM, Loh R, Sanfilippo FM, Clifford RM. Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement. Allergy Asthma Clin Immunol 2014; 10: 49.

32. Kapoor S, Roberts G, Bynoe Y, Gaughan M, Habibi P, Lack G. Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy 2004; 59: 185- 191.

33. Salter SM, Vale S, Sanfilippo FM, Loh R, Clifford RM. Long-term ffectiveness of online anaphylaxis education for pharmacists. Am J Pharm Educ 2014; 78: 136.

34. Mohammed Elhassan S, Charlson M, Jama H, et al. Management of anaphylaxis in children: a survey of parents and school personnel in Qatar. BMJ Paediatr Open 2017; 1: e000077.

35. Korematsu S, Fujitaka M, Ogata M, et al. Administration of the adrenaline auto-injector at the nursery/kindergarten/school in Western Japan. Asia Pac Allergy 2017; 7: 37-41.

36. Özen A, Boran P, Torlak F, et al. School board policies on prevention and management of anaphylaxis in İstanbul: where do we stand? Balkan Med J 2016; 33: 539-542.

37. Tsuang A, Demain H, Patrick K, Pistiner M, Wang J. Epinephrine use and training in schools for foodinduced anaphylaxis among non-nursing staff. J Allergy Clin Immunol Pract 2017; 5: 1418-1420.e3.

38. Devetak I, Devetak SP, Vesel T. Future teachers’ attitudes and knowledge regarding the management of the potential students’ life-threatening allergic reactions in Slovenian schools. Zdr Varst 2018; 57: 124-132.

39. Bakirtas A, Arga M, Catal F, Derinoz O, Demirsoy MS, Turktas I. Make-up of the epinephrine autoinjector: the effect on its use by untrained users. Pediatr Allergy Immunol 2011; 22: 729-733.

40. Waserman S, Avilla E, Ben-Shoshan M, Rosenfield L, Adcock AB, Greenhawt M. Epinephrine autoinjectors: new data, new problems. J Allergy Clin Immunol Pract 2017; 5: 1180-1191.